RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer transplant study tests safer drug combo to prevent deadly complication
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to find which of two drug combinations (cyclosporine and sirolimus with either MMF or post-transplant cyclophosphamide) better prevents a serious side effect call…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
New drug combo aims to keep relapsed myeloma in check after transplant
Disease control TerminatedThis study tested whether a combination of daratumumab and pomalidomide could help control multiple myeloma that has returned after a stem cell transplant. The trial included 13 adults with relapsed disease. The goal was to see if this maintenance therapy could achieve complete r…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC